Hot Features
Premium
Register for real-time alerts, custom portfolio, and market movers
Period:
Draw Mode:
| Volume | 144,955 |
|
|||||
| News | - | ||||||
| Day High | 7.19 | Low High |
|||||
| Day Low | 6.95 | ||||||
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| Aura Biosciences Inc | AURA | NASDAQ | Common Stock |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| 0.03 | 0.43% | 7.06 | 19:00:00 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 7.03 | 6.95 | 7.19 | 7.06 | 7.03 |
| Trades | Shares Traded | VWAP | Financial Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 2,067 | 144,955 | US$ 7.08 | US$ 1,026,836 | - | 5.99 - 13.50 |
| Last Trade | Type | Quantity | Price | Currency |
|---|---|---|---|---|
| 16:04:11 | 1 | US$ 7.06 | USD |
Aura Biosciences Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 271.26M | 38.26M | - | 0 | -76.41M | -2.00 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Aura Biosciences News
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical AURA Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 7.70 | 7.82 | 6.95 | 7.35 | 99,322 | -0.64 | -8.31% |
| 1 Month | 8.43 | 8.74 | 6.95 | 7.66 | 132,389 | -1.37 | -16.25% |
| 3 Months | 7.55 | 9.72 | 6.95 | 7.88 | 187,423 | -0.49 | -6.49% |
| 6 Months | 8.55 | 12.35 | 5.99 | 8.04 | 204,783 | -1.49 | -17.43% |
| 1 Year | 8.99 | 13.50 | 5.99 | 8.77 | 136,209 | -1.93 | -21.47% |
| 3 Years | 14.10 | 26.16 | 5.99 | 11.52 | 111,521 | -7.04 | -49.93% |
| 5 Years | 14.10 | 26.16 | 5.99 | 11.52 | 111,521 | -7.04 | -49.93% |
Aura Biosciences Description
| Aura Biosciences Inc is a clinical-stage oncology company developing a novel technology platform based on virus-like drug conjugates to target and destroy cancer cells selectively while activating the immune system to create long-lasting anti-tumor immunity. |
